IL312885A - Nitroxoline for use in the treatment or prevention of flexiform neurofibroma - Google Patents
Nitroxoline for use in the treatment or prevention of flexiform neurofibromaInfo
- Publication number
- IL312885A IL312885A IL312885A IL31288524A IL312885A IL 312885 A IL312885 A IL 312885A IL 312885 A IL312885 A IL 312885A IL 31288524 A IL31288524 A IL 31288524A IL 312885 A IL312885 A IL 312885A
- Authority
- IL
- Israel
- Prior art keywords
- nitroxoline
- prevention
- treatment
- plexiform neurofibroma
- plexiform
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2116743.2A GB202116743D0 (en) | 2021-11-19 | 2021-11-19 | Treatment |
| PCT/GB2022/052933 WO2023089328A1 (en) | 2021-11-19 | 2022-11-18 | Nitroxoline for use in the treatment or prevention of a plexiform neurofibroma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL312885A true IL312885A (en) | 2024-07-01 |
Family
ID=79163954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL312885A IL312885A (en) | 2021-11-19 | 2022-11-18 | Nitroxoline for use in the treatment or prevention of flexiform neurofibroma |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250000852A1 (enExample) |
| EP (1) | EP4433054B1 (enExample) |
| JP (1) | JP2024540439A (enExample) |
| KR (1) | KR20240108407A (enExample) |
| CN (1) | CN118215479A (enExample) |
| AU (1) | AU2022392456A1 (enExample) |
| CA (1) | CA3238805A1 (enExample) |
| GB (1) | GB202116743D0 (enExample) |
| IL (1) | IL312885A (enExample) |
| MX (1) | MX2024006105A (enExample) |
| WO (1) | WO2023089328A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202218460D0 (en) * | 2022-12-08 | 2023-01-25 | Healx Ltd | Treatment |
| WO2026022492A1 (en) * | 2024-07-26 | 2026-01-29 | Healx Limited | Nitroxoline for use in the treatment and/or prevention of pain |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102239149B (zh) * | 2008-10-06 | 2015-05-13 | 约翰·霍普金斯大学 | 喹啉化合物作为血管新生、人类甲硫氨酰氨肽酶、以及sirt1的抑制剂,以及治疗病症的方法 |
| GB202108224D0 (en) * | 2021-06-09 | 2021-07-21 | Healx Ltd | Treatment |
-
2021
- 2021-11-19 GB GBGB2116743.2A patent/GB202116743D0/en not_active Ceased
-
2022
- 2022-11-18 CN CN202280074138.9A patent/CN118215479A/zh active Pending
- 2022-11-18 IL IL312885A patent/IL312885A/en unknown
- 2022-11-18 JP JP2024527790A patent/JP2024540439A/ja active Pending
- 2022-11-18 CA CA3238805A patent/CA3238805A1/en active Pending
- 2022-11-18 AU AU2022392456A patent/AU2022392456A1/en active Pending
- 2022-11-18 US US18/710,477 patent/US20250000852A1/en active Pending
- 2022-11-18 EP EP22812750.2A patent/EP4433054B1/en active Active
- 2022-11-18 WO PCT/GB2022/052933 patent/WO2023089328A1/en not_active Ceased
- 2022-11-18 KR KR1020247016458A patent/KR20240108407A/ko active Pending
- 2022-11-18 MX MX2024006105A patent/MX2024006105A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2024006105A (es) | 2024-05-30 |
| CA3238805A1 (en) | 2023-05-25 |
| CN118215479A (zh) | 2024-06-18 |
| EP4433054B1 (en) | 2026-07-08 |
| JP2024540439A (ja) | 2024-10-31 |
| EP4433054A1 (en) | 2024-09-25 |
| AU2022392456A1 (en) | 2024-05-23 |
| WO2023089328A1 (en) | 2023-05-25 |
| KR20240108407A (ko) | 2024-07-09 |
| GB202116743D0 (en) | 2022-01-05 |
| US20250000852A1 (en) | 2025-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269354A (en) | Compounds useful in the treatment or prevention of a prmt5-mediated disorder | |
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| PH12021551455A1 (en) | Jak1 pathway inhibitors for the treatment of gastrointestinal disease | |
| EP3672594A4 (en) | COMBINATION PRODUCT OF BCL -2 INHIBITOR AND MDM2 INHIBITOR, AND USE OF THE LATTER IN THE PREVENTION AND / OR TREATMENT OF DISEASES | |
| EP3603636A4 (en) | COMPOSITION TARGETING S1PR4 TO PREVENT OR TREAT NON-ALCOHOLIC STEATOHEPATITIS | |
| EP3501527C0 (en) | COMPOSITION FOR PREVENTING OR TREATING A MENTAL DISORDER, CONTAINING A VESICLE DERIVED FROM BACTERIA OF AN ELACTOBACILLUS SPECIES | |
| EP3448421A4 (en) | METHOD AND COMPOSITIONS FOR PREVENTING AND TREATING SURGICAL ADHESIVES | |
| ZA202103977B (en) | Compounds and their use for the treatment of alpha1-antitrypsin deficiency | |
| KR102217525B9 (ko) | 치주염 예방 또는 치료용 유산균 및 그의 용도 | |
| HRP20260406T1 (hr) | Lumateperon za primjenu u liječenju shizofrenije | |
| EP3677265C0 (en) | COMPOSITION FOR PREVENTING OR TREATMENT OF SLEEP DISORDERS | |
| ZA202307970B (en) | Compounds for use in the treatment and prevention of covid- 19 | |
| IL280197A (en) | Methods for treatment and prevention of multiple sclerosis using substituted amino-pyrimidine compounds | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| EP3558335A4 (en) | INHIBITION OF CASPASE-1 AND ITS USES IN THE PREVENTION AND TREATMENT OF NEUROLOGICAL CONDITIONS | |
| IL286437A (en) | Materials and methods for enhanced treatment and prevention of biofilms | |
| IL284124A (en) | Quinoline derivatives for use in the treatment or prevention of cancer | |
| EP3632430A4 (en) | AGENTS FOR THE PREVENTION OR TREATMENT OF SPINOCERBELLARY ATAXIA | |
| EP3610879A4 (en) | COMPOSITION OF TREATMENT AND / OR PREVENTION OF ALZHEIMER'S DISEASE | |
| IL309177A (en) | Nitroxoline for use in the treatment of cutaneous neurofibroma | |
| GB201918404D0 (en) | Compounds and their use for the treatment of aplha1-antitrypsin deficiency | |
| EP3750529A4 (en) | COMPOSITION FOR THE PREVENTION AND TREATMENT OF SPINAL MARSION LESIONS | |
| IL309355A (en) | Compositions and their use for the treatment of α1-antitrypsin deficiency | |
| HUE066609T2 (hu) | Adagolási forma betegség kezelésében vagy megelõzésében történõ alkalmazásra | |
| KR102217518B9 (ko) | 치주염 예방 또는 치료용 유산균 및 그의 용도 |